RRoche Read More Roche gets FDA Priority Review for Enspryng TED2026-06-30 Roche (OTCQX:RHHBY) received FDA Priority Review for a supplemental Biologics License Application for…
RRoche Read More How the Narrative Around Roche Is Evolving Amid Analyst Updates and Clinical Shifts2026-02-17 Roche Holding’s fair value estimate has seen a modest increase, with the latest target rising from CHF 298.64…